An announcement from BriaCell Therapeutics ( ($TSE:BCT) ) is now available. BriaCell Therapeutics announced positive results from its Phase 2 and ...

The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate ...

The use of real-world evidence (RWE) began gaining traction decades ago, primarily as a response to the limitation around ...

Cathy graduated from Indiana University Southeast with a bachelor's degree in English. Over her nine-year content writing career, Cathy has developed a knack for untangling complex information and ...

Last week, you might have seen that Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) released its second-quarter result to the market. The early response was not positive, with shares down 8.3% ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that ...

Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) study portfolio with tools across the Medidata Platform for the past 17 years, strengthening the collaboration and reinforcing ...

Nurix Therapeutics, Inc. has announced a webcast conference call scheduled for June 12, 2025, at 8:00 a.m. ET to discuss new data from its ongoing Phase 1 clinical trial of bexobrutideg (NX-5948), ...

Nkarta, Inc. (NASDAQ:NKTX) reported a fourth-quarter earnings report on Wednesday with a loss of 35 cents per share, beating the consensus of a loss of 41 cents. The company announced restructuring ...

BriaCell Therapeutics ( ($TSE:BCT) ) has provided an update. BriaCell Therapeutics Corp. announced its selection to present key clinical data at ...